Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China · Delayed Price · Currency is CNY 5.31
+0.11 (2.12%)
Aug 20, 2026, 3:04 PM CST
SHE:002793 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 798.45 | 550.11 | 456.68 | 692.9 | 1,434 | 2,002 |
Short-Term Investments | - | - | - | - | - | 20.03 |
Trading Asset Securities | 8 | 4 | 1.25 | 2.1 | 17.1 | 12.58 |
Cash & Short-Term Investments | 806.45 | 554.11 | 457.93 | 695 | 1,451 | 2,034 |
Cash Growth | 93.86% | 21.00% | -34.11% | -52.10% | -28.68% | 57.99% |
Accounts Receivable | 339.83 | 441.45 | 601.57 | 598.89 | 996.3 | 3,255 |
Other Receivables | 157.36 | 171.88 | 158.71 | 217.41 | 1,269 | 80.46 |
Receivables | 497.19 | 613.34 | 760.28 | 816.3 | 2,266 | 3,336 |
Inventory | 347.33 | 323.62 | 459.56 | 455.61 | 684.99 | 709.08 |
Other Current Assets | 104.65 | 437.87 | 106.62 | 100.6 | 320.34 | 289.32 |
Total Current Assets | 1,756 | 1,929 | 1,784 | 2,068 | 4,722 | 6,368 |
Property, Plant & Equipment | 730.86 | 759.34 | 1,296 | 1,630 | 1,777 | 2,071 |
Long-Term Investments | 271.29 | 202.91 | 243.12 | 245.06 | 231.96 | 65.24 |
Goodwill | 1.95 | 1.95 | 1.95 | 1.95 | 4.38 | 9.76 |
Other Intangible Assets | 385.86 | 396.55 | 487.37 | 476.24 | 392.81 | 338.11 |
Long-Term Deferred Tax Assets | 171.32 | 184.91 | 188.39 | 286.15 | 428.61 | 183.67 |
Long-Term Deferred Charges | 213.73 | 210.65 | 204.61 | 244.17 | 281.37 | 371.45 |
Other Long-Term Assets | 38.48 | 40.03 | 129.68 | 166.77 | 280.59 | 89.14 |
Total Assets | 3,569 | 3,725 | 4,336 | 5,117 | 8,119 | 9,497 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 497.72 | 499.42 | 544.1 | 384.89 | 512.25 | 899.77 |
Accrued Expenses | 99.8 | 244.45 | 233.3 | 255.18 | 252.25 | 479.23 |
Short-Term Debt | 1,025 | 876.93 | 742.08 | 555.6 | 2,402 | 1,945 |
Current Portion of Long-Term Debt | 158.14 | 2.1 | 591.52 | 405.65 | 821.15 | 275.53 |
Current Portion of Leases | - | 69.58 | 70.7 | 63.73 | 65.44 | 12.81 |
Current Income Taxes Payable | 14 | 0.79 | 1.01 | 1.79 | 10.83 | 61.81 |
Current Unearned Revenue | 49.55 | 53.32 | 66.04 | 134.28 | 169.28 | 152.12 |
Other Current Liabilities | 463.64 | 551.47 | 289.23 | 116.43 | 141.13 | 181.1 |
Total Current Liabilities | 2,308 | 2,298 | 2,538 | 1,918 | 4,375 | 4,007 |
Long-Term Debt | - | 92 | 133.38 | 429.23 | 190.93 | 567.13 |
Long-Term Leases | 44.03 | 57.2 | 102.64 | 66.09 | 142.02 | 57.13 |
Long-Term Unearned Revenue | 21.22 | 22.28 | 78.92 | 89.93 | 93.58 | 102.22 |
Long-Term Deferred Tax Liabilities | - | - | 7.36 | 7.58 | 10.29 | - |
Other Long-Term Liabilities | 20.81 | 20.07 | 16.29 | 34.6 | - | 27.28 |
Total Liabilities | 2,394 | 2,490 | 2,877 | 2,545 | 4,812 | 4,761 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,088 | 1,088 | 1,088 | 1,088 | 1,088 | 1,464 |
Additional Paid-In Capital | 310.21 | 397.04 | 380.18 | 472.99 | 514.77 | 175.4 |
Retained Earnings | -341.87 | -366.02 | -77.44 | 888.05 | 1,549 | 2,789 |
Treasury Stock | - | - | -30 | - | - | -40.66 |
Comprehensive Income & Other | 43.88 | 45.43 | 21.95 | 21.27 | 23.33 | -2.74 |
Total Common Equity | 1,100 | 1,164 | 1,382 | 2,470 | 3,175 | 4,385 |
Minority Interest | 75.39 | 71.66 | 77.13 | 102.51 | 132.37 | 351.2 |
Shareholders' Equity | 1,175 | 1,236 | 1,459 | 2,572 | 3,307 | 4,736 |
Total Liabilities & Equity | 3,569 | 3,725 | 4,336 | 5,117 | 8,119 | 9,497 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,227 | 1,098 | 1,640 | 1,520 | 3,622 | 2,858 |
Net Cash (Debt) | -420.73 | -543.68 | -1,182 | -825.31 | -2,171 | -823.17 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.40 | -0.51 | -1.11 | -0.76 | -1.52 | -0.57 |
Filing Date Shares Outstanding | 1,088 | 1,088 | 1,061 | 1,088 | 1,088 | 1,464 |
Total Common Shares Outstanding | 1,088 | 1,088 | 1,061 | 1,088 | 1,088 | 1,464 |
Working Capital | -552.24 | -369.11 | -753.6 | 149.96 | 347.07 | 2,361 |
Book Value Per Share | 1.01 | 1.07 | 1.30 | 2.27 | 2.92 | 3.00 |
Tangible Book Value | 711.99 | 765.53 | 892.96 | 1,992 | 2,778 | 4,037 |
Tangible Book Value Per Share | 0.65 | 0.70 | 0.84 | 1.83 | 2.55 | 2.76 |
Buildings | - | 872.38 | 1,119 | 1,071 | 1,068 | 1,227 |
Machinery | - | 1,156 | 1,365 | 1,321 | 1,376 | 1,376 |
Construction In Progress | - | 6.3 | 20.43 | 336.86 | 294.22 | 362.38 |